*** EJNMMI Research accepted for ISI coverage and will receive its first Impact Factor in 2016. ***
EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.
Erratum to: The ultimate radiochemical nightmare: upon radio-iodination of Botulinum neurotoxin A, the introduced iodine atom itself seems to be fatal for the bioactivity of this macromolecule
Janneke van Uhm (January 2016)
- Available 2011 - 2016
- Volumes 6
- Issues 6
- Articles 347
- Open Access 346 Articles
Find a Volume or Issue
- Journal Title
- EJNMMI Research
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
- Volume 1 / 2011 - Volume 6 / 2016
- Online ISSN
- Springer Berlin Heidelberg
- Additional Links
To view the rest of this content please follow the download PDF link above.